This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Hashtag: #HeartFailure2025 European Atherosclerosis Society (EAS) Congress 2025 Date: May 4-7, 2025 Location: Glasgow, UK and online Overview: The European Atherosclerosis Society (EAS) and the British Atherosclerosis Society (BAS) will be hosting the 93 rd EAS Congress, to be held in the city of Lyon.
European Atherosclerosis Society (EAS) Congress 2024 Date: May 26-29, 2024 Location: Lyon, France and online Overview: The European Atherosclerosis Society (EAS) and the New French Society of Atherosclerosis will be hosting the 92 nd EAS Congress, to be held in the city of Lyon. Hashtag: #ICNCCT2024 7.
milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: CardiovascularImaging on March 13, 2024.
Circulation: CardiovascularImaging, Ahead of Print. It is well understood that cancer therapies including chemotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors, and radiation can increase the risk of cardiovascular disease in patients with cancer.
25, 2024 in the European Heart Journal CardiovascularImaging. 25, 2024 in the European Heart Journal CardiovascularImaging 1. 25, 2024 in the European Heart Journal CardiovascularImaging 1. In Press European Heart Journal CV Imag 2024.This This study was sponsored by Cleerly, Inc. James Min, M.D.
Presence of atherosclerosis with LDL-C and HBA1c in the ‘normal range’ What the above graph shows is that for those with an LDL-C of 3.4 EuropeanHeartJournal-CardiovascularImaging(2020)21,1177–1183 3 Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
Circulation: CardiovascularImaging, Ahead of Print. BACKGROUND:Intensive lipid-lowering therapy may induce coronary atherosclerosis regression. Nevertheless, the factors underlying the effect of lipid-lowering therapy on disease regression remain poorly characterized.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e015712, February 1, 2024. BACKGROUND:Coronary artery calcium computed tomography (CAC) is an important tool for identifying subclinical atherosclerosis and cardiovascular risk stratification.
The Category I CPT code is an addition to the Category III CPT codes (CPT 0623T, 0624T, 0625T, 0626T) used for reporting Cleerly’s advanced coronary atherosclerosis analysis. in European Association of CardiovascularImaging: Late Breaking Clinical Research and Trials. Barcelona, Spain. Chiou A, Hermel M, Miller G et al.
Circulation: CardiovascularImaging, Ahead of Print. BACKGROUND:Immune checkpoint inhibitors (ICIs), though revolutionary in cancer treatment, may accelerate atherosclerosis by inducing arterial inflammation.
Circulation: CardiovascularImaging, Volume 17, Issue 2 , Page e016057, February 1, 2024. BACKGROUND:Sex-specific differences in coronary phenotypes in response to stress have not been elucidated.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content